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Background
Transmyocardial laser revascularization is an indirect
method of treatment CAD. Many authors underline bene-
fits from TMLR as an additional procedure for patients in
whom complete revascularization is not reachable. Chan-
nels created by the laser stimulate inflammation, which
results in TMLR-related neoangiogenesis.
The aim of the study was to establish the long-term
follow-up after TMLR.
Methods
95 patients admitted for elective CABG with TMLR or
isolated TMLR between 1997 and 2002 (using HOLIUM:
YAG laser). In 11 cases (11.6%) cases only TMLR was
applied.
Results
Perioperative mortality was of 7.4%, long-term follow-up
revealed 13.3% mortality, with 50% rate of cardiac asso-
ciated deaths. MACE-free rate during 10 to 15 years fol-
low-up period amounts 63.3%. General incidence of
myocardial infarct (MI) after the procedure accounted
for 34.5%. The improvement of the quality of life ascer-
tained by patients was observed in all cases. Patients
were we divided into two groups based on whether LAD
grafting was (56.7%) or was not (43.3%) performed. In
23.5% cases with LAD graft, TMLR was also applied to
the anterior myocardium. Improvement of the quality of
life assessed by the EQ-5D scale is higher in patients
without LAD grafting (42.5 vs. 31.25) (p = 0.215).
Patients with LAD bypass graft benefited lower MI inci-
dence and mortality in long-term follow-up (33.3% vs.
41.7% for MI incidence and 7.7% vs. 23.1% for mortal-
ity). Applying TMLR at anterior wall additionally to
bypass grafting on LAD resulted in only 25% MI incidence
and no deaths in long-term follow-up.
Conclusions
This study indicates a significant effect on angina relief
in patients, who received TMLR, measured by the EQ-
5D scale. We believe that in patients with end-stage
CAD TMLR should be applied as an additional proce-
dure to direct revascularization. Beneficial influence of
this combined procedure was confirmed by diminished
incidence of MI and death in the long-term follow-up.
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